Combination immunotherapeutic strategies for haematological cancers

淋巴瘤患者最初对治疗反应良好，但后来病情复发。免疫系统可以有效地控制癌症。一种潜在的治疗选择是增强对癌症的自然免疫反应。本研究研究了一种新型疫苗，该疫苗通过传递NKT细胞激活分子来激活某种免疫细胞NKT细胞来对抗淋巴瘤。结果将允许评估基于nkt的疫苗与现有淋巴瘤治疗方法的结合。

Patients with lymphoma cancers initially respond well to treatment, but later relapse with disease. The immune system can be effective at controlling cancer. A potential treatment option is to boost the natural immune response against cancer. This study investigates a novel vaccine that activates a certain immune cell, NKT cells, to fight lymphomas by delivering an NKT cell-activating molecule. Outcomes will allow assessment of combining an NKT-based vaccine with established treatments for lymphoma.